Zepbound
Tirzepatide injection
FDA-approved· Eli LillyWeekly dual-action injection for chronic weight management, dispensed by a licensed US pharmacy.
Starting at $449/mo
$1,099
after provider approval
Start intakeNo charge until a licensed provider approves your treatment.
Reviewed by US-licensed providers
Free, discreet shipping
This treatment requires a licensed provider review. Start your intake instead.
Licensed US providers Free shipping over $50 HIPAA-secure
What to expect
Day 0
Intake
A short online medical questionnaire, reviewed against your history.
Day 1–2
Provider review
A US-licensed provider reviews and messages you with any questions.
Day 2–4
Pharmacy ships
If approved, a licensed US pharmacy fills and ships your order.
Day 4–7
Arrives
Discreet, tracked delivery. Follow-up care is included.
Timelines are estimates and depend on provider review and pharmacy fulfillment. No medication is dispensed without a valid prescription.
Clinical notes
Titrated from 2.5 mg to a maintenance dose. In SURMOUNT-1, participants on the highest dose lost about 21% of body weight over 72 weeks.
Regulatory notice
This product is FDA-approved for its labeled indication. A licensed provider determines whether it is appropriate for you. Prescription required.
Prescription products require an online consultation with a licensed provider. Pricing shown is the cash-pay rate if treatment is approved; you will not be charged for medication unless a provider approves it.
Related treatments
Best valueCompounded Semaglutide
Semaglutide (compounded)
Starting at $129/mo$297
after provider approval
Compounded · not FDA-approvedBest valueCompounded Tirzepatide
Tirzepatide (compounded)
Starting at $219/mo$349
after provider approval
Compounded · not FDA-approvedBestseller